Investigating the feasibility of a group self-management program after stroke

Is it feasible to deliver a group self-management programme for stroke survivors? Exploring changes in outcomes as compared to a waitlist control group and pre-post intervention in quality of life, self-efficacy, activities of daily living and self-efficacy as well as qualitative outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN19867168

Enrollment

Registered

2016-12-20

Start date

2015-04-01

Completion date

Unknown

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Stroke, Primary sub-specialty: Rehabilitation Nervous System Diseases Stroke

Interventions

Eligible participants will be randomised to either the intervention or the wait-list control group by the projects statistician. Due to the nature of the study it is not possible to bl

at the end of intervention, and then at 2-weeks and 6-months post intervention. The waitlist control group will not receive any interaction with the research team during a 6-month wai

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of stroke 2. Able to understand a 2-stage command either verbally or non-verbally 3. Able to understand English 4. At least 18 years’ old 5. Discharged from community rehabilitation services

Exclusion criteria

Exclusion criteria: 1. Any previous access or support from Bridges self-management programme 2. Severe aphasia and unable to understand a 2 stage command 3. Severe comorbidities such as malignancy or unstable cardiovascular condition 4. Clinically depressed 5. Unable to understand English and no family supporter/friend available

Design outcomes

Primary

Measure	Time frame
Quantitative outcomes: 1. Quality of life is measured using the stroke and aphasia quality of life scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 2. Self-efficacy is measured using the Stroke Self-efficacy Scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 3. Mood measured using the Hospital Anxiety and Depression Scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 4. Activities of daily living measured using the Nottingham Activities of Daily Living Scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention Feasibility outcomes: 1. SAQoL variability is assessed at baseline and end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 2. Attrition is assessed using session attendance logs kept throughout the trial period 3. Eligibility rate is assessed using recruitment logs during the recruitment period. 4. Follow up completion rate is assessed by recording the number of participants who complete all follow up measures at the end of the trial 5. Willingness of participants to be randomised is assessed using interviews post intervention. Qualitative outcomes: Acceptability and mechanisms of change are measured using interviews and focus groups which take place in the community.	—

Measure

Time frame

Quantitative outcomes: 1. Quality of life is measured using the stroke and aphasia quality of life scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 2. Self-efficacy is measured using the Stroke Self-efficacy Scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 3. Mood measured using the Hospital Anxiety and Depression Scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 4. Activities of daily living measured using the Nottingham Activities of Daily Living Scale at end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention Feasibility outcomes: 1. SAQoL variability is assessed at baseline and end of the waitlist period (if applicable), end of intervention as well at 2 weeks and 6 months (intervention group only) post intervention 2. Attrition is assessed using session attendance logs kept throughout the trial period 3. Eligibility rate is assessed using recruitment logs during the recruitment period. 4. Follow up completion rate is assessed by recording the number of participants who complete all follow up measures at the end of the trial 5. Willingness of participants to be randomised is assessed using interviews post intervention. Qualitative outcomes: Acceptability and mechanisms of change are measured using interviews and focus groups which take place in the community.

—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Contacts

Public ContactElla Clark

e.clark@ucl.ac.uk+44 (0)20 3448 8774

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026